Business · 14/06/2018Updated: 10/17/2026 · 1 min read
Ferring Pharmaceuticals, Inc. Sees FDA Withdraw Approval of Two Abbreviated New Drug Applications
Summary
The FDA is withdrawing approval of two abbreviated new drug applications from Ferring Pharmaceuticals, Inc. following a request from the company to discontinue marketing of the drug products.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →